Darren Kocs, MD, MHSA
Advertisement
Articles by Darren Kocs, MD, MHSA
Advertisement
Latest Updated Articles
- Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience
Published: May 1st 2003 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
2
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
3
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
4
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
5
